摘要
肝细胞癌(HCC)是一个恶性肿瘤,发病率和死亡率高、尤其是在东亚。治疗肝癌的基因治疗是一种潜在的方法。一个高效和安全的基因传递方法是肝癌基因治疗的关键因素。近年来,基因运载系统包括病毒和非病毒基因载体、细菌、和物理方法经历了实质性的发展。其中,各种非病毒基因载体得到了广泛和详细研究。因为它们是相对安全的、高容量。在本文中,我们关注当前和新兴肝癌传递技术并提出非病毒基因载体技术的使用和改进所涉及的挑战。
关键词: 基因治疗,肝癌,靶向性非病毒载体,物理治疗,病毒载体
Current Gene Therapy
Title:Current Status of Gene Therapy for Hepatocellular Carcinoma, with a Focus on Gene Delivery Approaches
Volume: 15 Issue: 2
Author(s): Xiaoyu Wang, Zongguang Tai, Wei Zhang and Shen Gao
Affiliation:
关键词: 基因治疗,肝癌,靶向性非病毒载体,物理治疗,病毒载体
摘要: Hepatocellular carcinoma (HCC) is a malignancy with high morbidity and mortality rates, especially in East Asia. Gene therapy is a potential approach for treating HCC. An efficient and safe gene delivery method is a crucial factor for HCC gene therapy. In recent years, gene delivery systems, including viral and non-viral gene vectors, bacteria, and physical methods, have undergone substantial development. Among them, various non-viral vectors have been studied widely and in detail because they are relatively safe and have a high capacity. In this review, we focus on current and emerging HCC delivery techniques and address the challenges involved in the use and improvement of non-viral vectors.
Export Options
About this article
Cite this article as:
Xiaoyu Wang, Zongguang Tai, Wei Zhang and Shen Gao , Current Status of Gene Therapy for Hepatocellular Carcinoma, with a Focus on Gene Delivery Approaches, Current Gene Therapy 2015; 15 (2) . https://dx.doi.org/10.2174/1566523214666141224095411
DOI https://dx.doi.org/10.2174/1566523214666141224095411 |
Print ISSN 1566-5232 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5631 |
Call for Papers in Thematic Issues
Programmed Cell Death Genes in Oncology: Pioneering Therapeutic and Diagnostic Frontiers (BMS-CGT-2024-HT-45)
Programmed Cell Death (PCD) is recognized as a pivotal biological mechanism with far-reaching effects in the realm of cancer therapy. This complex process encompasses a variety of cell death modalities, including apoptosis, autophagic cell death, pyroptosis, and ferroptosis, each of which contributes to the intricate landscape of cancer development and ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Therapeutic Strategies for Targeting BRAF in Human Cancer
Reviews on Recent Clinical Trials RNA Interference as Therapeutics for Hepatocellular Carcinoma
Recent Patents on Anti-Cancer Drug Discovery Applications of Important Polysaccharides in Drug Delivery
Current Pharmaceutical Design Long Chain n-3 Polyunsaturated Fatty Acids in the Prevention of Allergic and Cardiovascular Disease
Current Pharmaceutical Design Nuclear Hormone Receptors and Female Reproduction
Current Molecular Medicine Multiple-Target Drugs: Inhibitors of Heat Shock Protein 90 and of Histone Deacetylase
Current Drug Targets The Role of Cellular Plasticity in Cancer Development
Current Medicinal Chemistry Recent Developments to Improve the Efficacy of Cytotoxic Nucleoside Analogues
Recent Patents on Anti-Cancer Drug Discovery Gene Transfer to the Central Nervous System: Current State of the Art of the Viral Vectors
Current Genomics Inhibition of Autophagy Strengthens Celastrol-Induced Apoptosis in Human Pancreatic Cancer In Vitro and In Vivo Models
Current Molecular Medicine Drugging Cell Cycle Kinases in Cancer Therapy
Current Drug Targets Synthesis, Biological Evaluation and Molecular Dynamics Simulation Studies of Novel Diphenyl Ethers
Medicinal Chemistry Aminopeptidases of Malaria Parasites: New Targets for Chemotherapy
Infectious Disorders - Drug Targets Diketoacid Inhibitors of HIV-1 Integrase: From L-708,906 to Raltegravir and Beyond
Current Medicinal Chemistry Prognostic and Therapeutic Implications of MicroRNA in Malignant Pleural Mesothelioma
MicroRNA Anti-Cancer Activity of Nitrones and Observations on Mechanism of Action
Anti-Cancer Agents in Medicinal Chemistry The ErbB Receptors and their Ligands in Cancer: An Overview
Current Drug Targets Nanomedicine: A New Frontier in Cancer Therapeutics
Current Drug Delivery Polymorphisms of Human N-Acetyltransferases and Cancer Risk
Current Drug Metabolism Proteomic Identification of a Monoclonal Antibody Recognizing Caveolin-1 in Hepatocellular Carcinoma with Metastatic Potential
Protein & Peptide Letters